China Digest: Cyagen snags $41m; Alibaba-backed Amwise raises $10m

China’s transgenic animal models provider Cyagen Biosciences has raised 285 million yuan ($41 million) from CMS Capital, Grower Venture Capital, GF Qianhe and GF Investment. In a separate development, Alibaba-backed Amwise has secured $10 million in its Series B round led by Simcere Medical Diagnosis.